Table 1.
Basal characteristics of subjects.
| Treatment (N = 37) | Placebo (N = 39) | P value* | |
|---|---|---|---|
| Age (years) | 45.6 ± 9.9 | 46.8 ± 10.3 | 0.615 |
| Age of onset of hair loss (years) | 34.2 ± 8.6 | 36.8 ± 9.8 | 0.223 |
| The Norwood-Hamilton grade | 0.373 | ||
| Stage 2 | 8 (21.6) | 4 (10.3) | |
| Stage 3 | 5 (13.5) | 2 (5.1) | |
| Stage 3V | 11 (29.7) | 15 (38.5) | |
| Stage 4 | 7 (18.9) | 8 (20.5) | |
| Stage 5 | 6 (16.2) | 10 (25.6) | |
| Family history of androgenetic alopecia | 27 (73.0) | 27 (69.2) | 0.719 |
| Smoking (pack-year) | 5.9 ± 8.8 | 2.6 ± 6.4 | 0.067 |
| Body mass index (kg/m2) | 24.7 ± 2.9 | 24.5 ± 2.9 | 0.734 |
Data are expressed as means ± SD or frequency (percent).
*Two-sample Student's t-test or chi-square test.